Zealand Pharma A/S ADR (ZEAL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ZEAL | BMY | AMGN | GILD | REGN |
| Company | Zealand Pharma A/S ADR | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 18.03 | 49.00 | 269.84 | 66.93 | 904.54 |
| High | 18.07 | 49.56 | 273.14 | 67.57 | 908.67 |
| Low | 17.47 | 48.87 | 269.84 | 66.74 | 897.45 |
| Last | 17.59 | 49.14 | 271.91 | 66.95 | 900.16 |
| Change | +0.21 | +0.21 | +2.98 | +0.19 | +3.34 |
| % Change | +1.21% | +0.43% | +1.11% | +0.28% | +0.37% |
| Volume | 2,100 | 7,929,500 | 2,165,700 | 5,622,300 | 351,300 |
| 20-Day Average Volume | 2,250 | 11,113,590 | 2,239,560 | 6,350,505 | 441,525 |
| Previous Close | 17.38 | 48.93 | 268.93 | 66.76 | 896.82 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 18.09 | 50.71 | 272.35 | 69.61 | 931.83 |
| 20-Day Raw Stochastic | 27.14% | 22.23% | 40.27% | 13.17% | 11.27% |
| 20-Day Relative Strength | 50.34% | 42.35% | 47.06% | 32.36% | 36.34% |
| Weighted Alpha | -38.80 | -25.43 | +10.54 | -20.99 | +12.76 |
| Today's Opinion | 48% Buy | 88% Sell | 40% Sell | 100% Sell | 24% Buy |
| Previous Opinion | 32% Buy | 72% Sell | 56% Sell | 100% Sell | 24% Buy |
| Last Month's Opinion | 24% Buy | 24% Sell | 8% Buy | 88% Sell | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.11% since 09/21/22 | +1.30% since 04/15/24 | +2.41% since 04/15/24 | -1.18% since 04/15/24 | +0.18% since 04/15/24 |
| Low | 16.54 on 09/27/22 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 890.43 on 04/16/24 |
| High | 18.07 on 09/29/22 | 49.56 on 04/22/24 | 273.14 on 04/22/24 | 67.89 on 04/16/24 | 920.73 on 04/19/24 |
| 1-Month | |||||
| %Chg | +2.45% since 08/29/22 | -5.37% since 03/22/24 | -1.54% since 03/22/24 | -7.80% since 03/22/24 | -6.94% since 03/22/24 |
| Low | 16.51 on 09/19/22 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 890.43 on 04/16/24 |
| High | 20.03 on 09/09/22 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 976.75 on 03/27/24 |
| 3-Month | |||||
| %Chg | +32.96% since 06/29/22 | -0.87% since 01/22/24 | -12.33% since 01/22/24 | -14.64% since 01/22/24 | -4.53% since 01/22/24 |
| Low | 12.82 on 07/01/22 | 47.58 on 02/06/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 890.43 on 04/16/24 |
| High | 20.49 on 08/25/22 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 81.06 on 01/25/24 | 998.33 on 02/28/24 |
| 6-Month | |||||
| %Chg | +20.23% since 03/29/22 | -12.96% since 10/20/23 | -2.47% since 10/20/23 | -13.95% since 10/20/23 | +11.34% since 10/20/23 |
| Low | 9.93 on 05/16/22 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 769.19 on 10/27/23 |
| High | 20.49 on 08/25/22 | 56.77 on 10/25/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 998.33 on 02/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 818,603 | 99,594,944 | 145,845,984 | 83,357,904 | 98,803,360 |
| Shares Outstanding, K | 46,538 | 2,026,759 | 536,376 | 1,245,077 | 109,762 |
| Annual Sales | 46,550,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 13,117,200,000 |
| Annual Net Income | -161,990,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,953,600,000 |
| Last Quarter Sales | 4,060,000 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 3,434,300,000 |
| Last Quarter Net Income | -69,960,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 | 1,159,600,000 |
| 60-Month Beta | 1.45 | 0.39 | 0.58 | 0.19 | 0.11 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.40 on 08/11/22 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 11.86 on 02/02/24 |
| Latest Earnings Date | 11/10/22 | 04/25/24 | 05/02/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.52 | 14.42 | 9.93 | 23.86 |